IL-4 and IL-5 expressions were previously quantified in intestinal tissue and correlated with the clinical and histological severity of colitis in UC patients [5], and IL-13, which was also found to be up-regulated in UC, was linked to an impaired epithelial barrier function in the gut [6]. The gene discussed is IL5; the disease is colitis.